Related Experiment Video
Updated: Jun 17, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Severe ifosfamide-induced neurotoxicity: a case report
Sara Ramos Linares1, Joaquín Breña Atienza, Matilde Cháfer Rudilla
1Pharmacy Department, Hospital Universitario Nuestra Señora de Candelaria, Carretera del Rosario n masculine 145. 38010, Santa Cruz de Tenerife, Spain. sramlin@gobiernodecanarias.org
Ifosfamide, an alkylating agent, can cause severe neurotoxicity in cancer patients. Early recognition and management of risk factors are crucial for patient safety during chemotherapy.
Area of Science:
- Oncology
- Pharmacology
- Neuroscience
Background:
- Ifosfamide is a vital alkylating agent for treating various cancers.
- Accumulation of ifosfamide metabolites can lead to significant neurotoxicity.
Observation:
- A case report details a patient with Hodgkin's lymphoma experiencing severe neurological toxicity after ifosfamide treatment.
- The patient had prior cisplatin chemotherapy, low albumin, and rapid ifosfamide infusion.
Findings:
- Neurological toxicity resolved with supportive care within three weeks.
- Risk factors identified include prior cisplatin, hypoalbuminemia, and rapid infusion of ifosfamide.
Implications:
- Clinicians must be vigilant for severe neurological toxicity associated with ifosfamide.
- Identifying and managing risk factors may mitigate ifosfamide-induced neurotoxicity.
Related Concept Videos
Drug Toxicity: Risk factors
Drug Toxicity: Overview
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug toxicity: Idiosyncratic Reactions
Pharmaceutical Poisoning: Treatment Strategies
Drug Toxicity: Dose-Dependent Reactions